AMAG Pharmaceuticals Inc. [AMAG] stock is up 1.41 while the S&P 500 has fallen -0.65% on Wednesday, 10/14/20. While at the time of this article, AMAG ATR is sitting at 0.55, with the beta value at 1.13. This stock’s volatility for the past week remained at 1.04%, while it was 4.08% for the past 30-day period. AMAG has risen $0.19 from the previous closing price of $13.45 on volume of 1.34 million shares.

On 15, October 2020, Covis Group S.à r.l. Announces Commencement of Tender Offer for All Outstanding Shares of AMAG Pharmaceuticals, Inc.. According to news published on Yahoo Finance, Covis Group S.à r.l. (“Covis”) announced the commencement of a cash tender offer to purchase all of the outstanding shares of common stock of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) (“AMAG”). The tender offer is being made pursuant to the merger agreement (the “Merger Agreement”) announced by Covis and AMAG on October 1, 2020 under which Covis has agreed to acquire AMAG for $13.75 per share. The transaction has a total enterprise value of approximately $647 million, including net debt.

Analyst Birdseye View:

The most recent analyst activity for AMAG Pharmaceuticals Inc. [NASDAQ:AMAG] stock was on October 30, 2019, when it was Downgrade with an Underweight rating from Piper Jaffray, which also lowered its 12-month price target on the stock from $9 to $6. Before that, on August 18, 2020, Barclays Recapitulated an Equal weight rating and elevated its amount target to $10. On August 01, 2019, H.C. Wainwright Initiated a Buy rating and boosted its price target on this stock to $16. On June 11, 2019, Barclays Initiated an Overweight rating and increased its price target to $19. On March 20, 2019, SunTrust Initiated a Hold rating. On December 14, 2018, B. Riley FBR Reiterated a Buy rating and boosted its amount target on this stock to $20.50. On November 06, 2018, JP Morgan Downgrade an Underweight rating.

In the past 52 weeks of trading, this stock has oscillated between a low of $4.41 and a peak of $13.80. Right now, the middling Wall Street analyst 12-month amount mark is $13.75. At the most recent market close, shares of AMAG Pharmaceuticals Inc. [NASDAQ:AMAG] were valued at $13.64. According to the average price forecast, investors can expect a potential return of 13.02%.

FUNDAMENTAL ANALYSIS

AMAG Pharmaceuticals Inc. [NASDAQ:AMAG] most recently reported quarterly sales of 52.76 billion, which represented growth of -32.40%. This publicly-traded organization’s revenue is $742,150 per employee, while its income is -$1,062,866 per employee. This company’s Gross Margin is currently 64.00%, its Operating Margin is -79.70%, its Pretax Margin is -143.23, and its Net Margin is -143.21. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -47.56, -91.12, -16.44 and -59.00 respectively.

The Principal structure of this organization shows its whole liability to whole principal at 51.82 and the whole liability to whole assets at 38.03. It shows enduring liability to the whole principal at 51.11 and enduring liability to assets at 0.38 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 13.34 points at 1st support level, the second support level is making up to 13.22. But as of 1st resistance point, this stock is sitting at 13.58 and at 13.70 for 2nd resistance point.

AMAG Pharmaceuticals Inc. [AMAG] reported its earnings at -$0.23 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.19/share signifying the difference of -0.04 and -21.10% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were -$0.3 calling estimates for -$0.03/share with the difference of -0.27 depicting the surprise of -900.00%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for AMAG Pharmaceuticals Inc. [NASDAQ:AMAG] is 1.60. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.80. Now if looking for a valuation of this stock’s amount to sales ratio it’s 1.27 and it’s amount to book ratio is 1.48.

Insider Stories

The most recent insider trade was by Camber Capital Management LP, 10% Owner, and it was the sale of 4.39 million shares on Oct 01. ARMISTICE CAPITAL, LLC, the 10% Owner, completed a purchase of 24000.0 shares on Mar 16. On Feb 25, ARMISTICE CAPITAL, LLC, 10% Owner, completed a purchase of 36000.0 shares.